1. Home
  2. ADXN vs GXAI Comparison

ADXN vs GXAI Comparison

Compare ADXN & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • GXAI
  • Stock Information
  • Founded
  • ADXN 2002
  • GXAI 2021
  • Country
  • ADXN Switzerland
  • GXAI United States
  • Employees
  • ADXN N/A
  • GXAI N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • GXAI
  • Sector
  • ADXN Health Care
  • GXAI
  • Exchange
  • ADXN Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • ADXN 10.1M
  • GXAI 9.7M
  • IPO Year
  • ADXN N/A
  • GXAI 2023
  • Fundamental
  • Price
  • ADXN $9.48
  • GXAI $1.33
  • Analyst Decision
  • ADXN Strong Buy
  • GXAI
  • Analyst Count
  • ADXN 1
  • GXAI 0
  • Target Price
  • ADXN $30.00
  • GXAI N/A
  • AVG Volume (30 Days)
  • ADXN 17.4K
  • GXAI 143.7K
  • Earning Date
  • ADXN 08-11-2025
  • GXAI 08-12-2025
  • Dividend Yield
  • ADXN N/A
  • GXAI N/A
  • EPS Growth
  • ADXN N/A
  • GXAI N/A
  • EPS
  • ADXN 0.10
  • GXAI N/A
  • Revenue
  • ADXN $278,508.00
  • GXAI $27,740.00
  • Revenue This Year
  • ADXN $86.57
  • GXAI N/A
  • Revenue Next Year
  • ADXN N/A
  • GXAI N/A
  • P/E Ratio
  • ADXN $0.76
  • GXAI N/A
  • Revenue Growth
  • ADXN N/A
  • GXAI 9987.27
  • 52 Week Low
  • ADXN $6.51
  • GXAI $1.00
  • 52 Week High
  • ADXN $13.27
  • GXAI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 59.29
  • GXAI 46.56
  • Support Level
  • ADXN $8.99
  • GXAI $1.30
  • Resistance Level
  • ADXN $9.89
  • GXAI $1.65
  • Average True Range (ATR)
  • ADXN 0.81
  • GXAI 0.10
  • MACD
  • ADXN 0.06
  • GXAI -0.00
  • Stochastic Oscillator
  • ADXN 78.07
  • GXAI 17.57

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: